Entellus Medical (NSDQ:ENTL) said today that it struck a deal to be acquired by Stryker (NYSE:SYK) for $662 million in cash. Plymouth, Minn.-based Entellus, founded in 2006, makes a family of minimally invasive balloon device products, including its flagship Xpress device, that are designed to treat blocked sinuses. Earlier this year it closed the $81 million […]
Wall Street Beat
Edwards Lifesciences raises 2017 outlook, details 2018 goals
Edwards Lifesciences (NYSE:EW) today raised its outlook for the rest of this year and set its goals for the coming year, saying it expects to post earnings growth of about 12% on a roughly 9% sales gain in 2018 and pledging “aggressive” investment in R&D. The Irvine, Calif.-based heart valve maker, which yesterday acquired mitral valve […]
Nemaura Medical touts precision data for non-invasive glucose monitor
Nemaura Medical (OTC:NMRD) touted precision data today from the on-going European clinical trial program of its non-invasive, needle-free glucose monitoring system, sugarBeat. The study included 16 patients with Type I and Type II diabetes. The participants wore two sugarBeat skin-patches simultaneously over 3 days for up to 14 hours each day. Get the full story at […]
Robocath adds $2m for new neurovascular platform
Medical robotics startup Robocath said today that it added about $2 million (€1.7 million) to the more than $5 million it raised earlier this year, taking its total to $7.5 million in funding this year. Rouen, France-based Robocath, which is developing the R-One robotic platform for coronary angioplasty, is pursuing CE Mark approval in the European Union for […]
Report: OrbiMed founder Sam Isaly harassed women for years, according to former employees
Several former employees of biotech hedge fund OrbiMed have alleged that Sam Isaly, the firm’s founder & managing partner, sexually harassed his female colleagues for years, according to an investigation by STAT. Isaly is a 72-year-old investor who has long been revered among the biotech community for his ability to pick stocks. But at OrbiMed, former […]
Smith & Nephew closes $210m Rotation Medical buy
Smith & Nephew (NYSE:SNN) said today that it closed the $210 million acquisition of Rotation Medical and its regenerative shoulder repair treatment. The deal called for the British orthopedics and wound care giant to pay $125 million in up-front cash, with another $85 million on the line over the next five years in financial milestones. Plymouth, Minn.-based Rotation’s […]
How and when to outsource product development
Sometimes, it makes sense for a medtech company to outsource product development to bring their device to market faster and more efficiently. MassDevice.com editor Sarah Faulkner spoke to Minnetronix‘s VP of business development and marketing, Jim Reed, about how and when medtech companies should consider outsourcing product development to a partner. Faulkner: How should companies […]
Novo Nordisk’s once-weekly Type II diabetes injection wins FDA nod
Novo Nordisk‘s (NYSE:NVO) once-weekly semaglutide injection, Ozempic, has won FDA approval as a therapy for adults with Type II diabetes, the insulin-maker reported today. The injection, given in a pre-filled pen, is a GLP-1 analogue – a drug that trigger the production of insulin, while lessening appetite and food intake. Get the full story at […]
Titan Medical closes upsized $18m round
Titan Medical (TSX:TMD) said today that it closed a funding round that brought in nearly $4 million more than it was originally expecting, grossing more than $18 million for the Sport robot-assisted surgery device it’s developing. Last month the Toronto-based company upsizedthe previously announced offering to between $14.1 million and $18 million ((C$18 million to C$23 million), up from […]
Lilly launches trial for automated insulin delivery system
Eli Lilly (NYSE:LLY) yesterday dosed the first patient in a trial of its automated insulin delivery system. The system is a hybrid closed-loop platform that includes a connected insulin pump, a dosing algorithm and a continuous glucose monitor. Get the full story at our sister site, Drug Delivery Business News.
HeartFlow stakes $90m step toward $150m Series E
HeartFlow took a $90 million step toward the $150 million it hopes to raise in a Series E round for the cardiac imaging technology it’s marketing. Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing the changes in flow across […]